Status:
RECRUITING
Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Differentiated Thyroid Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
Background: Despite the good prognosis of patients with differentiated thyroid carcinomas (DTC), the diagnosis of cancer, fear of cancer recurrence and its side effects might still bring impacts on pa...
Detailed Description
Phase I is a cross-sectional survey study (first year) with the specific aims to examine the current status of physical distress (fatigue, sleep dysfunction, other symptoms), psychological distress (f...
Eligibility Criteria
Inclusion
- newly diagnosed DTC patients
- after received thyroid tumor excision operation (total thyroidectomy)
Exclusion
- primary unknown
- conscious unclear
- recurrence or with bone meta
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT03757637
Start Date
December 1 2018
End Date
December 31 2025
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, National Taiwan University Hospital, No.7, Chung-Shan South Road, Taipei, TAIWAN, R.O.C.
Taipei, Taiwan, 100